The assortment of drugs on the Swedish market has been analysed in order to illustrate its current structure and its qualitative and quantitative changes. The analysis comprises both active substances and pharmaceutical specialities, and it has in several cases been divided into different pharmacological groups and into Swedish and imported products. The main aspects are: market life of products introduced since 1960; withdrawal of drugs; age of the current assortment of drugs; structural changes during 15 years; new drugs introduced since 1960; combinations; synonyms.
No takes yet. Share an insight, caveat, or question.
Berlin et al. (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: